Part 1: What Is a Freedom-to-Operate Analysis (and What Isn’t It)?
The Freedom to Operate (FTO) Deep Dive: Questions Your Company Should Be Asking
This is Part 1 of a six-part series on freedom-to-operate analysis. The series walks through what an FTO assessment is, why it matters, how it works, what to do with the results, how it changes for software, AI, and international products, and the most common ways it goes wrong. See the full table of contents here.
Part 1: What Is a Freedom-to-Operate Analysis (and What Isn’t It)?
Getting surprised by a patent suit can be substantially mitigated through a competent FTO search and analysis of any relevant patents surfaced in the search. This post covers what an FTO assessment actually is, what it isn’t, and the misconceptions that lead companies to either skip it entirely or rely on it for things it can’t do.
What is a Freedom-to-Operate Analysis?
A freedom-to-operate analysis (FTO for short) is a legal assessment of whether a specific product or process, sold in specific places, could infringe any unexpired and valid patent claims of patent identified through an FTO search of otherwise.
That definition has a lot of qualifiers in it on purpose. An FTO applies to a defined product, in defined jurisdictions, at a defined point in time, against the patents that are identified through a defined search or any other way (for example, being told by a competitor, being identified during internal research, or being found during product development). Change any of those variables, and the answer can change.
The question is not: “Has anybody ever had this idea before?” or “Is anybody else doing something similar?” The question is more like: “Does anybody own a valid, enforceable patent that has claims that could prevent me from selling this specific product in this particular market?”
An FTO assessment can be communicated, in many cases, through an oral or short written document. In some cases, an FTO assessment can result in a formal written legal opinion. A good one is a structured, defensible analysis by someone who knows what they’re doing. That’s worth a lot, but it’s still not a magic shield.
What is an FTO assessment not?
FTO assessments ask, “Can I sell this product without infringing the valid patent rights of others?” They get confused with several things they are note. The most common confusions:
Not a Patentability Analysis. Patentability asks a different question: “Can I get a patent on this invention?” Different questions, different searches, different answers. Why the difference? Because any publication can prevent you from getting a patent, so the scope of the search is much broader for a patentability analysis. A patentability analysis is less concerned with the particulars of the claims of the references and focuses more on the overall disclosure of the reference. Put another way, it’s possible for there to be a reference that prevents you from getting a patent on your invention but does not prevent you from being able to sell your invention without liability exposure.
Not Merely an Invalidity Opinion. Validity asks whether a particular patent should have issued in the first place. Invalidity can certainly be part of an FTO opinion, but the primary question of an FTO assessment is infringement.
Not a Guarantee That You Won’t Be Sued. Even the best FTO opinion can miss things, including unpublished applications, obscure patents, patents in seemingly unrelated industries, and claims that have not yet been amended. And despite a great FTO assessment, a zealous patent owner may sue you, and/or a judge or a jury may still find infringement.
Not Permanent. An FTO assessment is a snapshot. Your product changes. The patent landscape changes. Five years later, an FTO opinion will generally have limited current value.
Doesn’t My Own Patent Give Me Freedom to Operate?
No. Your patent does not protect you from infringing someone else’s patent. This is the single most common misconception I see from clients. It’s a bit counterintuitive, and it makes a lot more sense to patent lawyers than to business teams.
Your patent says your invention is novel and non-obvious. It gives you the right to exclude others from practicing your claims, but it does not give you the affirmative right to practice your claims. It says nothing about whether your own product infringes someone else’s broader patent.
The classic example of this is an improvement patent. Imagine someone patents a chair. Years later, you patent a chair with a specific ergonomic curve in the back. Your improvement patent on the specific ergonomic curve is perfectly valid. But if you actually build and sell that chair, you’re still making a chair, and the original chair patent owner can assert infringement. Your patent functions as an offensive tool. You can stop others from copying your specific curve, and you can use it as a bargaining chip in cross-licensing negotiations. Defense against someone else’s patent isn’t part of what it does.
What If Nobody Else Is Selling Anything Like My Invention?
This is one of the most common reasons companies skip an FTO assessment, and it’s also one of the riskiest. The patent system doesn’t require the patent owner to actually build, sell, or even try to commercialize their own patent. Plenty of valid, enforceable patents cover products that never reached the market, were abandoned years ago, or only ever existed as a research project. The patent owner can sit on the patent for almost its entire 20-year term and assert it the day you start shipping at scale. Patent assertion entities exist precisely because of this: they buy patents from companies that didn’t commercialize, and they make money by suing the companies that did.
The other half of the problem here is that “nobody else is selling it” might just mean you haven’t found them (yet). Competitors in adjacent markets, foreign companies that haven’t entered the United States yet, university spinouts, stealth-mode startups, and large companies running internal projects can all be working on something similar without showing up in your competitive market research. A market scan tells you who’s visible, but it doesn’t tell you who’s patented.
What If Others Are Selling a Similar Product?
This is the question that comes up more often in practice than “nobody else is selling it.” Business teams point to several visible competitors and conclude that the space must be safe: “They’re all selling, and they haven’t been sued.” But this doesn’t necessarily mean that selling is safe, for a few reasons.
A patent owner can pick and choose who they assert against. Patent owners commonly hold their fire against competitors with deep pockets, complex cross-licensing exposure, or counter-assertion portfolios, and instead (or initially) pursue smaller or newer entrants where the litigation economics are more favorable. The fact that an established player isn’t being asserted against tells you very little about whether you would be.
Other companies in the space may also be operating under licenses, design-arounds, or settlement agreements that you don’t know about and can’t see. Or the patent owner may simply be working through targets in a deliberate order. Visibility of competitors is not evidence of clearance. It just tells you the space is interesting enough that someone is likely paying attention.
If We Searched and Found Nothing, Are We Good to Go?
No. Search has some structural limits that no methodology can overcome. A few reasons an FTO assessment is inherently under-inclusive:
The 18-month Publication Blackout. Patent applications stay secret for 18 months after their earliest priority date. There’s a real possibility that a patent application targeting your product was filed last week, and nobody (not you, not your patent counsel, not even competitors) can see it for another year and a half. This is particularly true for new and fast-changing technologies, such as AI.
Pending Applications Change Shape. Even when an application is published, the claims in it might get amended, broadened (within limits), or rewritten before they issue. The claims you see today aren’t necessarily the claims that will eventually be enforceable. Pending applications that are concerning are generally flagged in an FTO assessment as something to keep an eye on.
Continuations. A competitor who filed a broad patent application years ago can keep a continuation alive and draft new claims today, claims informed by your product, that get the benefit of the original priority date. More on this below.
Search Isn’t Perfect. Even great searchers using great tools can miss patents that use unfamiliar terminology, sit in obscure classifications, or come from non-English-language priority chains.
Even the best FTO assessment will have limits, but it recognizes its limits. The output is a structured account of what was found, what it means, and what the search couldn’t see.
An FTO assessment is a useful tool when you understand what it actually is and what it isn’t. It’s a scoped analysis of a specific product, in specific places, against the patents the searcher could find. It isn’t a market scan, a patentability analysis, a validity opinion, a guarantee, or a permanent clearance. Misunderstanding any of those is how companies either skip the FTO assessment entirely (because they think their own patent protects them) or rely on it for things it can’t do (like guaranteeing they won’t face infringement liability or get sued).
Part 2 picks up the next question: given those caveats, why is an FTO worth doing at all? The answer comes down to litigation risk, willfulness, and timing.